Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Sign in for free

Phase

early phase 1 (1)

phase 2 (1)

Sponsor

David Dickens (1)

National Cancer Institute (NCI) (1)

Collaborator

Intervention

ascorbate (1)

gemcitabine (1)

ipilimumab (1)

laboratory biomarker analysis (1)

nivolumab (1)

quality-of-life assessment (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

unresectable bone sarcoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Locally Advanced Bone Sarcoma, Locally Advanced Dedifferentiated Liposarcoma, Locally Advanced Gastrointestinal Stromal Tumor

Active, not recruiting

Locally Advanced Bone Sarcoma
+20 more

Ipilimumab
+3 more

Anchorage, Alaska
+650 more

Oct 18, 2022

Soft Tissue Sarcoma, Bone Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate, Gemcitabine)

Not yet recruiting

Soft Tissue Sarcoma
+5 more

Iowa City, Iowa

University of Iowa Hospitals & Clinics

Sep 16, 2022